154 related articles for article (PubMed ID: 38516682)
21. ARID1A loss correlates with mismatch repair deficiency and intact p53 expression in high-grade endometrial carcinomas.
Allo G; Bernardini MQ; Wu RC; Shih IeM; Kalloger S; Pollett A; Gilks CB; Clarke BA
Mod Pathol; 2014 Feb; 27(2):255-61. PubMed ID: 23887303
[TBL] [Abstract][Full Text] [Related]
22. ACTL6A Promotes the Proliferation of Esophageal Squamous Cell Carcinoma Cells and Correlates with Poor Clinical Outcomes.
Li RZ; Li YY; Qin H; Li SS
Onco Targets Ther; 2021; 14():199-211. PubMed ID: 33469301
[TBL] [Abstract][Full Text] [Related]
23. The genetic landscape of endometrial clear cell carcinomas.
DeLair DF; Burke KA; Selenica P; Lim RS; Scott SN; Middha S; Mohanty AS; Cheng DT; Berger MF; Soslow RA; Weigelt B
J Pathol; 2017 Oct; 243(2):230-241. PubMed ID: 28718916
[TBL] [Abstract][Full Text] [Related]
24. Recurrent Somatic Copy Number Alterations and Their Association with Oncogene Expression Levels in High-Grade Ovarian Serous Carcinoma.
Esplen HP; Yang RK; Kalia A; Tang Z; Tang G; Medeiros LJ; Toruner GA
Life (Basel); 2023 Nov; 13(11):. PubMed ID: 38004332
[TBL] [Abstract][Full Text] [Related]
25. KAT6A amplifications are associated with shorter progression-free survival and overall survival in patients with endometrial serous carcinoma.
Saglam O; Tang Z; Tang G; Medeiros LJ; Toruner GA
PLoS One; 2020; 15(9):e0238477. PubMed ID: 32877461
[TBL] [Abstract][Full Text] [Related]
26. The gene copy number of c-MET has a significant impact on progression-free survival in Korean patients with ovarian carcinoma.
Kim WY; Shim SH; Jung HY; Dong M; Kim SN; Lee SJ
Hum Pathol; 2017 Jun; 64():98-105. PubMed ID: 28428108
[TBL] [Abstract][Full Text] [Related]
27. Integrin Subunit beta 8 (ITGB8) Upregulation Is an Independent Predictor of Unfavorable Survival of High-Grade Serous Ovarian Carcinoma Patients.
He J; Liu Y; Zhang L; Zhang H
Med Sci Monit; 2018 Dec; 24():8933-8940. PubMed ID: 30531684
[TBL] [Abstract][Full Text] [Related]
28. Potential Role of SWI/SNF Complex Subunit Actin-Like Protein 6A in Cervical Cancer.
Wang Q; Cao Z; Wei Y; Zhang J; Cheng Z
Front Oncol; 2021; 11():724832. PubMed ID: 34395295
[TBL] [Abstract][Full Text] [Related]
29. Inactivating mutations in SWI/SNF chromatin remodeling genes in human cancer.
Oike T; Ogiwara H; Nakano T; Yokota J; Kohno T
Jpn J Clin Oncol; 2013 Sep; 43(9):849-55. PubMed ID: 23904343
[TBL] [Abstract][Full Text] [Related]
30. The Emerging Role of Chromatin Remodeling Complexes in Ovarian Cancer.
VaicekauskaitÄ— I; SabaliauskaitÄ— R; Lazutka JR; JarmalaitÄ— S
Int J Mol Sci; 2022 Nov; 23(22):. PubMed ID: 36430148
[TBL] [Abstract][Full Text] [Related]
31. ACTL6A: unraveling its prognostic impact and paving the way for targeted therapeutics in carcinogenesis.
Eid RA; Mamdouh F; Abdulsahib WK; Alshaya DS; Al-Salmi FA; Ali Alghamdi M; Jafri I; Fayad E; Alsharif G; Zaki MSA; Alshehri MA; Noreldin AE; Alaa Eldeen M
Front Mol Biosci; 2024; 11():1387919. PubMed ID: 38872915
[No Abstract] [Full Text] [Related]
32. Mutation and loss of expression of ARID1A in uterine low-grade endometrioid carcinoma.
Guan B; Mao TL; Panuganti PK; Kuhn E; Kurman RJ; Maeda D; Chen E; Jeng YM; Wang TL; Shih IeM
Am J Surg Pathol; 2011 May; 35(5):625-32. PubMed ID: 21412130
[TBL] [Abstract][Full Text] [Related]
33. ACTL6A suppresses p21
Shrestha S; Adhikary G; Xu W; Kandasamy S; Eckert RL
Oncogene; 2020 Sep; 39(36):5855-5866. PubMed ID: 32616890
[TBL] [Abstract][Full Text] [Related]
34. PTEN Deficiency in Tubo-Ovarian High-Grade Serous Carcinoma is Associated with Poor Progression-Free Survival and is Mutually Exclusive with CCNE1 Amplification.
Zhang X; Wang A; Han L; Liang B; Allard G; Diver E; Howitt BE
Mod Pathol; 2023 May; 36(5):100106. PubMed ID: 36805789
[TBL] [Abstract][Full Text] [Related]
35. Clinical implications of next-generation sequencing-based panel tests for malignant ovarian tumors.
Saotome K; Chiyoda T; Aimono E; Nakamura K; Tanishima S; Nohara S; Okada C; Hayashi H; Kuroda Y; Nomura H; Susumu N; Iwata T; Yamagami W; Kataoka F; Nishihara H; Aoki D
Cancer Med; 2020 Oct; 9(20):7407-7417. PubMed ID: 32813918
[TBL] [Abstract][Full Text] [Related]
36. Amplification of the bromodomain-containing protein 4 gene in ovarian high-grade serous carcinoma is associated with worse prognosis and survival.
Ucar D; Lin DI
Mol Clin Oncol; 2015 Nov; 3(6):1291-1294. PubMed ID: 26807235
[TBL] [Abstract][Full Text] [Related]
37. Actin-like 6A enhances the proliferative and invasive capacities of laryngeal squamous cell carcinoma by potentiating the activation of YAP signaling.
Dang Y; Zhang L; Wang X
J Bioenerg Biomembr; 2020 Dec; 52(6):453-463. PubMed ID: 33067739
[TBL] [Abstract][Full Text] [Related]
38. Prognostic impact of HER3 based on protein and mRNA expression in high-grade serous ovarian carcinoma.
Unger U; Denkert C; Braicu I; Sehouli J; Dietel M; Loibl S; Darb-Esfahani S
Virchows Arch; 2017 Feb; 470(2):143-151. PubMed ID: 27913862
[TBL] [Abstract][Full Text] [Related]
39. Clinicopathological and prognostic significance of SWI/SNF complex subunits in undifferentiated gastric carcinoma.
Zhang Z; Li Q; Sun S; Li Z; Cui ZG; Zhang M; Liu Q; Zhang Y; Xiong S; Zhang S
World J Surg Oncol; 2022 Dec; 20(1):383. PubMed ID: 36464671
[TBL] [Abstract][Full Text] [Related]
40. Utility of a custom designed next generation DNA sequencing gene panel to molecularly classify endometrial cancers according to The Cancer Genome Atlas subgroups.
Miller EM; Patterson NE; Gressel GM; Karabakhtsian RG; Bejerano-Sagie M; Ravi N; Maslov A; Quispe-Tintaya W; Wang T; Lin J; Smith HO; Goldberg GL; Kuo DYS; Montagna C
BMC Med Genomics; 2020 Nov; 13(1):179. PubMed ID: 33256706
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]